Summary of Purpose
This is a randomized clinical trial of short-acting nimodipine versus twice daily extended release verapamil to treat patients presenting with Reversible Cerebral Vasoconstriction Syndrome (RCVS).Read More →
The following dates are available for this trial. Trial information last updated on 21 August 2017.
|1 Jul 2017||8 May 2017||31 May 2019||31 May 2019||1 Aug 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Interventions See All